Vivacitas Oncology Presents for the Second Year in a row at the 2022 SAPA Conference
Somerset, NJ, USA, October 1, 2022 – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a privately-held oncology company focused on tough–to–treat cancers, presents on October 1st, 2022 at the 2022 Sino-American Pharmaceutical Professional Association (SAPA) Conference. The SAPA Annual Conference is a tremendous platform for participants to share knowledge and viewpoints on important issues and […]